Literature DB >> 838871

Development and use of a micro haemagglutination inhibition (HAI) technique, based on Hepatest, for the detection and quantitation of hepatitis B surface antibody (Anti-HBs) in blood donors.

I C Wiseman.   

Abstract

A simple micro haemagglutination inhibition technique, based on Hepatest (Wellcome Reagents Limited), is described. Its application in the screening of blood donors is shown, and its sensitivity is discussed in two forms of usage and also when compared to the previous immunoelectroosmophoresis technique used in this centre.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 838871      PMCID： PMC476638          DOI： 10.1136/jcp.30.1.50

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  12 in total

1.  Editorial: Hepatitis B immune globulin: Evaluation of clinical trials and rationale for usage.

Authors:  H J Alter; L F Barker; P V Holland
Journal:  N Engl J Med       Date:  1975-11-20       Impact factor: 91.245

2.  A modification of Hepatest, using the Terasaki plate, for the detection of HBSAg in blood donors.

Authors:  I C Wiseman
Journal:  J Clin Pathol       Date:  1976-03       Impact factor: 3.411

3.  An immune hemagglutination procedure with very high sensitivity applied to the detection of hepatitis B antibody and antigen and immune complex.

Authors:  J H Pert; R L Verch
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

4.  Risk of transfusing blood containing antibody to hepatitis-B surface antigen.

Authors:  R D Aach; H J Alter; F B Hollinger; P V Holland; J J Lander; J L Melnick; J M Weiler
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

5.  Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis.

Authors:  A G Redeker; J W Mosley; D J Gocke; A P McKee; W Pollack
Journal:  N Engl J Med       Date:  1975-11-20       Impact factor: 91.245

6.  Letter: Infectivity of blood containing hepatitis-B antibody.

Authors:  P H Renton; L D Wadsworth
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

7.  Letter: Is blood containing anti-HBs infective?

Authors:  H Lehmann; M Schlaak
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

8.  Letter: Effectiveness of hepatitis-B immune globulin in haemodialysis patients.

Authors:  W Szmuness; A M Prince; J H Hoofnagle; S Ribot; M J Jacobs
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

9.  Hepatitis B immune globulin--prevention of hepatitis from accidental exposure among medical personnel.

Authors:  G F Grady; V A Lee
Journal:  N Engl J Med       Date:  1975-11-20       Impact factor: 91.245

10.  Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study.

Authors:  L B Seeff; E C Wright; J D Finkelstein; H B Greenlee; J Hamilton; C M Leevy; C H Tamburro; Z Vlahcevic; D S Zimmon; H J Zimmerman; B F Felsher; P Garcia-Pont; A A Dietz; R S Koff; T Kiernan; E R Schiff; R Zemel; N Nath
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321
View more
  1 in total

1.  Preparation and use of erythrocyte-globulin conjugates to Lassa virus in reversed passive hemagglutination and inhibition.

Authors:  R A Goldwasser; L H Elliott; K M Johnson
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.